TCL Archive Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation April 28, 2006
TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial July 4, 2014